Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
01/06/2024 | 16:00 | GlobeNewswire Inc. | Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC) | NASDAQ:BNTX | BioNTech SE |
29/05/2024 | 14:00 | GlobeNewswire Inc. | BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem | NASDAQ:BNTX | BioNTech SE |
27/05/2024 | 02:00 | PR Newswire (US) | MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership | NASDAQ:BNTX | BioNTech SE |
21/05/2024 | 22:36 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:BNTX | BioNTech SE |
21/05/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024 | NASDAQ:BNTX | BioNTech SE |
17/05/2024 | 17:15 | GlobeNewswire Inc. | BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 | NASDAQ:BNTX | BioNTech SE |
06/05/2024 | 14:09 | IH Market News | Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise | NASDAQ:BNTX | BioNTech SE |
06/05/2024 | 12:45 | GlobeNewswire Inc. | BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | NASDAQ:BNTX | BioNTech SE |
26/04/2024 | 13:48 | IH Market News | Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News | NASDAQ:BNTX | BioNTech SE |
24/04/2024 | 13:28 | IH Market News | Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News | NASDAQ:BNTX | BioNTech SE |
22/04/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 | NASDAQ:BNTX | BioNTech SE |
07/04/2024 | 20:00 | GlobeNewswire Inc. | Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer | NASDAQ:BNTX | BioNTech SE |
21/03/2024 | 12:17 | IH Market News | Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates | NASDAQ:BNTX | BioNTech SE |
20/03/2024 | 12:17 | IH Market News | U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip | NASDAQ:BNTX | BioNTech SE |
20/03/2024 | 11:15 | GlobeNewswire Inc. | BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update | NASDAQ:BNTX | BioNTech SE |
20/03/2024 | 11:00 | GlobeNewswire Inc. | BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer | NASDAQ:BNTX | BioNTech SE |
11/03/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024 | NASDAQ:BNTX | BioNTech SE |
11/03/2024 | 11:25 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTX | NASDAQ:BNTX | BioNTech SE |
07/03/2024 | 12:45 | GlobeNewswire Inc. | BioNTech Announces Planned Retirement of Sean Marett | NASDAQ:BNTX | BioNTech SE |
06/03/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024 | NASDAQ:BNTX | BioNTech SE |
05/03/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX | NASDAQ:BNTX | BioNTech SE |
29/02/2024 | 00:26 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:BNTX | BioNTech SE |
26/02/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:BNTX | BioNTech SE |
22/02/2024 | 11:45 | PR Newswire (US) | BioNTech SE Sued for Securities Law Violations - Contact The Gross Law Firm Before March 12, 2024 to Discuss Your Rights - BNTX | NASDAQ:BNTX | BioNTech SE |
15/02/2024 | 22:10 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:BNTX | BioNTech SE |
14/02/2024 | 13:26 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:BNTX | BioNTech SE |
09/02/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) Shareholders | NASDAQ:BNTX | BioNTech SE |
08/02/2024 | 11:45 | GlobeNewswire Inc. | BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs | NASDAQ:BNTX | BioNTech SE |
08/02/2024 | 11:45 | GlobeNewswire Inc. | BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs | NASDAQ:BNTX | BioNTech SE |
02/02/2024 | 11:45 | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioNTech SE of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2024 - (NASDAQ: BNTX) | NASDAQ:BNTX | BioNTech SE |